药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zuclopenthixol
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Ofatumumab
The risk or severity of adverse effects can be increased when Ofatumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Volociximab
The risk or severity of adverse effects can be increased when Volociximab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Catumaxomab
The risk or severity of adverse effects can be increased when Catumaxomab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Teplizumab
The risk or severity of adverse effects can be increased when Teplizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Reslizumab
The risk or severity of adverse effects can be increased when Reslizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Lexatumumab
The risk or severity of adverse effects can be increased when Lexatumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Lerdelimumab
The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Bivatuzumab
The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Sibrotuzumab
The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Apolizumab
The risk or severity of adverse effects can be increased when Apolizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Siplizumab
The risk or severity of adverse effects can be increased when Siplizumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Pertuzumab
The risk or severity of adverse effects can be increased when Pertuzumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Lucatumumab
The risk or severity of adverse effects can be increased when Lucatumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Teprotumumab
The risk or severity of adverse effects can be increased when Teprotumumab is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Coltuximab ravtansine
The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Trastuzumab deruxtecan.
Zuclopenthixol
XmAb 2513
The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Trastuzumab deruxtecan.
Zuclopenthixol
Carotuximab
The risk or severity of adverse effects can be increased when Carotuximab is combined with Trastuzumab deruxtecan.